Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re‐analysis of a meta‐analysis

We identified analytic limitations in a recent meta‐analysis and re‐examined the efficacy and safety associated with immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC) compared with standard therapies. Our findings mostly contradict conclusions from the previous study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shouhao, Shen, Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958338/
https://www.ncbi.nlm.nih.gov/pubmed/36852153
http://dx.doi.org/10.1002/jgh3.12856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958338/
https://www.ncbi.nlm.nih.gov/pubmed/36852153
http://dx.doi.org/10.1002/jgh3.12856

Ejemplares similares